A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Anaplastic Lymphoma
- Lymphoma, Nonhodgkin
- MDD
- MRD
- Pediatric Cancer
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 1 years and 18 years
- Gender
- Both males and females
Description
Research purpose: To study the efficacy and safety of SCCCG-ALCL-2017 regimen in children with systemic ALK-positive anaplastic large cell lymphoma. To explore the correlation between MDD or MRD in peripheral blood or bone marrow and the treat response and survival. To explore the feasibility of ris...
Research purpose: To study the efficacy and safety of SCCCG-ALCL-2017 regimen in children with systemic ALK-positive anaplastic large cell lymphoma. To explore the correlation between MDD or MRD in peripheral blood or bone marrow and the treat response and survival. To explore the feasibility of risk stratification combined with adverse pathological types, dangerous organ invasion and MDD. To investigate the effect of vinblastine maintenance chemotherapy on survival of patients with MRD-positive in peripheral blood after treatment.
Tracking Information
- NCT #
- NCT03971305
- Collaborators
- Not Provided
- Investigators
- Study Director: Sun Xiaofei Sun Yat-sen University
Get Well Soon